Defibrillator News and Research RSS Feed - Defibrillator News and Research

An implantable cardioverter defibrillator (ICD) is a small device that's placed in your chest or abdomen. This device uses electrical pulses or shocks to help control life-threatening, irregular heartbeats, especially those that could lead the heart to suddenly stop beating (sudden cardiac arrest). If the heart stops beating, blood stops flowing to the brain and other vital organs. This usually causes death if it's not treated in minutes.
MRI safe for patients with implantable cardiac devices

MRI safe for patients with implantable cardiac devices

The findings of a major study led by cardiovascular imaging specialists at Allegheny General Hospital, part of the Allegheny Health Network, suggest that magnetic resonance imaging is a safe and effective diagnostic procedure for patients with implantable cardiac devices. [More]
New study finds that living in high-rise buildings may affect survival after cardiac arrest

New study finds that living in high-rise buildings may affect survival after cardiac arrest

The number of people living in high-rise buildings in rising, but along with the convenience and panoramic views of a downtown condo comes a risk: a new study found that survival rates from cardiac arrest decrease the higher up the building a person lives. [More]
Cedars-Sinai researcher receives $2.5 million grant to develop risk assessment tool for sudden cardiac arrest

Cedars-Sinai researcher receives $2.5 million grant to develop risk assessment tool for sudden cardiac arrest

A Cedars-Sinai Heart Institute physician researcher has received a $2.5 million grant from the National Heart, Lung, and Blood Institute to develop a risk assessment tool that could identify patients susceptible to sudden cardiac arrest, a usually fatal heart rhythm malfunction. [More]
Rani Therapeutics, MedImmune collaborate to evaluate novel oral drug delivery platform

Rani Therapeutics, MedImmune collaborate to evaluate novel oral drug delivery platform

Rani Therapeutics announced today that it has entered into a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, to evaluate Rani's novel oral drug delivery platform. The companies have agreed to conduct feasibility studies over the next two years, in which Rani will test select biologic molecules in the area of metabolic disease to evaluate the oral delivery of these molecules. [More]
Pacemaker Induced Transient Asynchrony could help slow down progression of heart failure

Pacemaker Induced Transient Asynchrony could help slow down progression of heart failure

Johns Hopkins has demonstrated in animals that applying a pacemaker's mild electrical shocks to push the heart in and out of normal synchronized contraction for part of each day may be an effective way to slow down the progression of heart failure, a disorder that afflicts millions of Americans. [More]
LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent. [More]
Advances in leadless pacing: an interview with Dr. Reddy

Advances in leadless pacing: an interview with Dr. Reddy

Pacemakers have been around for a very long time, they're great devices, critical for many people who have slow heartbeats. While they're very effective, they have some issues. There are two main aspects relating to these issues. [More]
Researchers identify factors that increase risk of cardiac arrest during pediatric spine surgeries

Researchers identify factors that increase risk of cardiac arrest during pediatric spine surgeries

Although the vast majority of pediatric spine surgeries are safe, a handful of neuromuscular conditions seem to fuel the risk of cardiac arrest during such operations, according to research led by investigators at the Johns Hopkins Children's Center. [More]
Isosorbide mononitrate does not increase HFpEF patients' daily activity level

Isosorbide mononitrate does not increase HFpEF patients' daily activity level

Heart failure patients with preserved ejection fraction (HFpEF) -- where the heart becomes stiff and cannot relax or fill properly -- did not have increased exercise tolerance after taking isosorbide mononitrate, compared to a placebo, according to a study presented today at the American Heart Association's Scientific Sessions 2015. [More]
ACC's public reporting program provides information about hospitals' performance

ACC's public reporting program provides information about hospitals' performance

Heart disease patients and their caregivers can now search for in-depth data about their local hospitals and make informed decisions about their care through the American College of Cardiology's public reporting program. The first data release includes information about hospitals' performance in prescribing appropriate medication at hospital discharge. [More]
Miriam Hospital enrolling local participants for Parachute implant clinical trial to treat heart failure

Miriam Hospital enrolling local participants for Parachute implant clinical trial to treat heart failure

The Miriam Hospital is actively recruiting local participants for a U.S. clinical trial of the Parachute device for treating heart failure. The study is focused on determining if the new minimally invasive catheter-based device can slow the progression of heart failure, reduce repeat hospitalizations and death, and significantly improve quality of life for patients who experience enlargement of the left ventricle after a heart attack. [More]
Study: Blackouts, near drownings linked to sudden death risk

Study: Blackouts, near drownings linked to sudden death risk

The annual congress of the South African Heart Association is being held in Rustenburg from Oct. 25-28, 2015. Experts from the European Society of Cardiology will present a special programme. [More]
Dehaier secures medical device distribution bid for rural healthcare construction project supported by CDB

Dehaier secures medical device distribution bid for rural healthcare construction project supported by CDB

Dehaier Medical Systems Ltd., which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has won a medical device distribution bid for a new rural healthcare construction project supported by China Development Bank Corp. [More]
Scripps becomes first health care provider in San Diego County to implant Evera MRI SureScan ICD System

Scripps becomes first health care provider in San Diego County to implant Evera MRI SureScan ICD System

Scripps Health is the first health care provider in San Diego County to use the only implantable cardioverter defibrillator (ICD) device approved for use with magnetic resonance imaging (MRI) scans. [More]
New genetic cause identified for congenital heart arrhythmia

New genetic cause identified for congenital heart arrhythmia

Scientists at The Ohio State University Dorothy M. Davis Heart and Lung Research Institute have identified a new genetic cause for congenital heart arrhythmia. The results of their research are published online by the Proceedings of the National Academy of Sciences (PNAS). [More]
Study challenges new ESC Guidelines to identify high-risk HCM patients who need ICDs for prevention of sudden death

Study challenges new ESC Guidelines to identify high-risk HCM patients who need ICDs for prevention of sudden death

Hypertrophic cardiomyopathy (HCM), a genetic form of heart disease with thick heart walls, is the most common cause of sudden death in patients under 50. While only a minority of patients with HCM are at risk, the implantable cardioverter-defibrillator (ICD) can effectively prevent sudden death in those patients. [More]
European cardiomyopathies registry shows higher than expected use of defibrillators, genetic testing

European cardiomyopathies registry shows higher than expected use of defibrillators, genetic testing

The most representative snapshot of real world practice in cardiomyopathies in Europe has shown a higher than expected use of defibrillators and genetic testing. The baseline results of the ESC's EORP Cardiomyopathy Registry Pilot are presented for the first time today at ESC Congress 2015. [More]
Defibrillator does not improve outcomes in patients with CRT pacemaker

Defibrillator does not improve outcomes in patients with CRT pacemaker

Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort study presented for the first time today at ESC Congress1 and published in European Heart Journal. [More]
Benznidazole has significant antiparasitic activity, but does not reduce progression of Chagas cardiomyopathy

Benznidazole has significant antiparasitic activity, but does not reduce progression of Chagas cardiomyopathy

A 40 to 80 day treatment with the antiparasitic medication benznidazole significantly reduced parasite activity in the blood, but not progression, of serious heart problems over a 5-year period among patients with established Chagas disease (CD) cardiomyopathy, results of the BENEFIT trial show. [More]
Gene linked to sudden cardiac death in general population identified using ICD monitoring

Gene linked to sudden cardiac death in general population identified using ICD monitoring

A gene associated with sudden cardiac death in the general population has been identified using implantable cardioverter defibrillator (ICD) monitoring in research presented for the first time at ESC Congress today. [More]
Advertisement
Advertisement